Literature DB >> 19925942

Historical and changing epidemiology of healthcare-associated infections.

A Pearson1.   

Abstract

This review compares the historical perspectives on healthcare-associated infections (HCAIs) with the current changing epidemiological picture as it relates to these infections. Evidence in support of these changes is given using trends in mortality for Clostridium difficile and meticillin-resistant Staphylococcus aureus bacteraemia in England as examples. The impact of current intervention programmes which target these, and other HCAIs, is also considered and knowledge gaps and options for changes in public health strategy required to achieve further reductions in HCAIs in the National Health Service in England are identified.

Entities:  

Mesh:

Year:  2009        PMID: 19925942     DOI: 10.1016/j.jhin.2009.08.016

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  9 in total

1.  Initial efforts toward the optimization of arylomycins for antibiotic activity.

Authors:  Tucker C Roberts; Mark A Schallenberger; Jian Liu; Peter A Smith; Floyd E Romesberg
Journal:  J Med Chem       Date:  2011-06-28       Impact factor: 7.446

2.  Multidrug therapy and evolution of antibiotic resistance: when order matters.

Authors:  Gabriel G Perron; Sergey Kryazhimskiy; Daniel P Rice; Angus Buckling
Journal:  Appl Environ Microbiol       Date:  2012-06-22       Impact factor: 4.792

3.  Prophylactic negative wound therapy in laparotomy wounds (PROPEL trial): randomized controlled trial.

Authors:  Noel Edward Donlon; P A Boland; M E Kelly; K Schmidt; F Cooke; P M Neary; K M Barry; J V Reynolds
Journal:  Int J Colorectal Dis       Date:  2019-09-16       Impact factor: 2.571

4.  Optimization of a β-Lactam Scaffold for Antibacterial Activity via the Inhibition of Bacterial Type I Signal Peptidase.

Authors:  Chien-Hung Yeh; Shawn I Walsh; Arryn Craney; M Greg Tabor; Ana-Florina Voica; Ramkrishna Adhikary; Sydney E Morris; Floyd E Romesberg
Journal:  ACS Med Chem Lett       Date:  2018-03-15       Impact factor: 4.345

5.  Fidaxomicin inhibits spore production in Clostridium difficile.

Authors:  Farah Babakhani; Laurent Bouillaut; Abraham Gomez; Pamela Sears; Ly Nguyen; Abraham L Sonenshein
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

6.  Effects of operational decisions on the diffusion of epidemic disease: A system dynamics modeling of the MERS-CoV outbreak in South Korea.

Authors:  Nina Shin; Taewoo Kwag; Sangwook Park; Yon Hui Kim
Journal:  J Theor Biol       Date:  2017-03-27       Impact factor: 2.691

7.  Negative pressure wound therapy use to decrease surgical nosocomial events in colorectal resections (NEPTUNE): study protocol for a randomized controlled trial.

Authors:  Sami A Chadi; Kelly N Vogt; Sarah Knowles; Patrick B Murphy; Julie Ann Van Koughnett; Muriel Brackstone; Michael C Ott
Journal:  Trials       Date:  2015-07-30       Impact factor: 2.279

8.  Negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial.

Authors:  Patrick Murphy; Kevin Lee; Luc Dubois; Guy DeRose; Thomas Forbes; Adam Power
Journal:  Trials       Date:  2015-11-04       Impact factor: 2.279

9.  Prophylactic negative pressure wound therapy for closed laparotomy wounds: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Patrick Anthony Boland; Michael E Kelly; Noel E Donlon; Jarlath C Bolger; Brian J Mehigan; Paul H McCormick; John O Larkin
Journal:  Ir J Med Sci       Date:  2020-06-25       Impact factor: 2.089

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.